Solve GNE, founded in Los Angeles, California, is a medical organization dedicated to finding a cure for GNE Myopathy, a rare genetic disorder. The organization’s core mission is to advance novel medicines through human clinical trials, with a vision of eradicating this debilitating disease. Solve GNE focuses on community engagement and collaboration with leading researchers to develop effective treatments. Their services include funding research, facilitating clinical trials, and raising awareness about GNE Myopathy.

Notable affiliates include prominent researchers and partnerships with biotech firms like Gradalis. The organization has raised $2.5 million to support its initiatives and has made significant strides in gene therapy development. Solve GNE's impact is marked by its progress in advancing hereditary inclusion body myopathy research and its commitment to bringing novel therapies to clinical application, offering hope to patients worldwide.